Weld Capital Management’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-84,445
Closed -$702K 487
2019
Q4
$702K Sell
84,445
-1,918
-2% -$15.9K 0.14% 258
2019
Q3
$637K Buy
86,363
+70,880
+458% +$523K 0.12% 296
2019
Q2
$174K Buy
+15,483
New +$174K 0.03% 663
2019
Q1
Sell
-29,411
Closed -$444K 693
2018
Q4
$444K Buy
+29,411
New +$444K 0.1% 388